Revvity — The life sciences company advanced 6% after posting a second-quarter earnings beat.
Revvity's adjusted earnings of $1.22 per share topped the FactSet estimate of $1.12 per share.
The new Marvel movie topped $200 million at the domestic box office, a record opening weekend for an R-rated film.
Second-quarter adjusted earnings per share came in at 96 cents, versus the expected consensus estimate of 92 cents, per FactSet.
The stock plunged more than 40% in the previous session after Dexcom reported disappointing second-quarter results and offered weak guidance.
Persons:
Tesla, Morgan Stanley, Adam Jonas, Walt Disney, Dexcom, — CNBC's Sean Conlon, Michelle Fox, Alex Harring, Jesse Pound, Samantha Subin
Organizations:
Management, Guggenheim, Ford, Deutsche Bank, Walt Disney —, Marvel, Semiconductor —, Revenue, Dexcom, Health Canada